AVITA Medical (RCEL) Raw Materials (2018 - 2022)

AVITA Medical's Raw Materials history runs 5 years deep, the most recent figure standing at $1.1 million for Q4 2022.

• Quarterly Raw Materials fell 7.45% year-over-year to $1.1 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $1.1 million (down 7.45% YoY) and the FY2022 annual result came in at $1.1 million, down 7.45% from the prior year.
• Raw Materials was $1.1 million for Q4 2022 at AVITA Medical, down from $1.2 million in the prior quarter.
• Across five years, Raw Materials topped out at $1.2 million in Q4 2021 and bottomed at $589691.6 in Q2 2018.
• A 5-year average of $913402.2 and a median of $964500.0 in 2020 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2020 — Raw Materials soared 55.57% — and 2022, when it declined 7.45%.
• AVITA Medical's Raw Materials stood at $589691.6 in 2018, then advanced by 3.23% to $608721.6 in 2019, then soared by 55.57% to $947000.0 in 2020, then rose by 29.04% to $1.2 million in 2021, then decreased by 7.45% to $1.1 million in 2022.
• Business Quant data shows RCEL's Raw Materials at $1.1 million in Q4 2022, $1.2 million in Q4 2021, and $982000.0 in Q2 2021.